InsidersTradesSigma
Track the Neurizon Therapeutics Limited share price and the full directors' dealings record of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the supervision of ASX. Operating in the Health Care sector, Neurizon Therapeutics Limited has published 2 insider filings. Market capitalisation: €52.7m. The latest transaction was reported on 12 May 2026 (Other). Among the most active insiders: Dr. Michael Thurn. The full history is free.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,218 of 29,064 companies
25.2
score / 100
Value6
Quality44
FCF yld-33%
Earn yld-38%
EV/EBITDA·
ROE-138%
Gross mgn72%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 May 2026
Declarations2 total
ShareASXISIN AU0000357261ASX:2924-03089281-6A1325154
●
11ASX ↗
ShareASXISIN AU0000357261ASX:2924-03089273-6A1325148
2 of 2 declarations
关于 Neurizon Therapeutics Limited
Neurizon Therapeutics Limited 是一家专注于开发神经系统疾病创新疗法的公司。它在 XASX 市场上市。